[ad_1]
Equities research analysts expect Aurora Cannabis Inc. (NYSE:ACB) to post earnings per share (EPS) of ($0.18) for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Aurora Cannabis’ earnings. The lowest EPS estimate is ($0.21) and the highest is ($0.15). Aurora Cannabis reported earnings per share of ($0.28) in the same quarter last year, which suggests a positive year over year growth rate of 35.7%. The firm is expected to announce its next earnings results on Thursday, February 10th.
On average, analysts expect that Aurora Cannabis will report full-year earnings of ($0.59) per share for the current financial year, with EPS estimates ranging from ($0.69) to ($0.46). For the next year, analysts expect that the firm will post earnings of ($0.40) per share, with EPS estimates ranging from ($0.51) to ($0.31). Zacks’ EPS averages are a mean average based on a survey of research firms that cover Aurora Cannabis.
Aurora Cannabis (NYSE:ACB) last released its earnings results on Tuesday, November 9th. The company reported ($0.09) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.09. Aurora Cannabis had a negative return on equity of 9.09% and a negative net margin of 252.40%. The business had revenue of $47.74 million during the quarter, compared to the consensus estimate of $47.84 million.
Several research firms have recently weighed in on ACB. Jefferies Financial Group reiterated a “hold” rating on shares of Aurora Cannabis in a research report on Friday, October 1st. CIBC upgraded Aurora Cannabis from an “underperform” rating to a “neutral” rating in a research note on Wednesday, November 10th. Zacks Investment Research upgraded Aurora Cannabis from a “sell” rating to a “hold” rating in a research note on Thursday, September 30th. MKM Partners upgraded Aurora Cannabis from a “sell” rating to a “neutral” rating and raised their price target for the company from $6.00 to $7.00 in a research note on Tuesday, September 28th. Finally, Piper Sandler restated a “hold” rating and set a $7.00 price target on shares of Aurora Cannabis in a research note on Tuesday, September 28th. Four analysts have rated the stock with a sell rating and eight have assigned a hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $7.08.
NYSE:ACB opened at $5.41 on Friday. Aurora Cannabis has a twelve month low of $5.39 and a twelve month high of $18.98. The company has a market cap of $1.07 billion, a price-to-earnings ratio of -2.07 and a beta of 2.99. The stock has a fifty day simple moving average of $6.56 and a 200-day simple moving average of $7.11. The company has a current ratio of 5.42, a quick ratio of 4.13 and a debt-to-equity ratio of 0.18.
Institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. boosted its holdings in Aurora Cannabis by 6.2% in the second quarter. Vanguard Group Inc. now owns 5,846,785 shares of the company’s stock worth $52,855,000 after acquiring an additional 339,238 shares in the last quarter. Bank of Montreal Can boosted its holdings in Aurora Cannabis by 12.0% in the second quarter. Bank of Montreal Can now owns 941,048 shares of the company’s stock worth $8,760,000 after acquiring an additional 100,834 shares in the last quarter. TD Asset Management Inc. boosted its holdings in Aurora Cannabis by 7.8% in the third quarter. TD Asset Management Inc. now owns 659,000 shares of the company’s stock worth $4,562,000 after acquiring an additional 47,662 shares in the last quarter. Alberta Investment Management Corp boosted its holdings in Aurora Cannabis by 543.9% in the second quarter. Alberta Investment Management Corp now owns 593,700 shares of the company’s stock worth $5,370,000 after acquiring an additional 501,500 shares in the last quarter. Finally, Public Sector Pension Investment Board boosted its holdings in Aurora Cannabis by 3.1% in the third quarter. Public Sector Pension Investment Board now owns 531,515 shares of the company’s stock worth $3,680,000 after acquiring an additional 15,815 shares in the last quarter. Institutional investors own 17.17% of the company’s stock.
Aurora Cannabis Company Profile
Aurora Cannabis, Inc engages in the production, distribution and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.
Recommended Story: Basic Economics creates winners and losers
Get a free copy of the Zacks research report on Aurora Cannabis (ACB)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Should you invest $1,000 in Aurora Cannabis right now?
Before you consider Aurora Cannabis, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Aurora Cannabis wasn’t on the list.
While Aurora Cannabis currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
Source link
